Avidity Partners Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-99,000
| Closed | -$2.82M | – | 73 |
|
|
2024
Q3 | $2.82M | Sell |
99,000
-809,000
| -89% | -$23.1M | 0.14% | 71 |
|
|
2024
Q2 | $24M | Buy |
908,000
+403,000
| +80% | +$10.6M | 1.02% | 42 |
|
|
2024
Q1 | $16.3M | Buy |
505,000
+260,000
| +106% | +$8.4M | 0.53% | 54 |
|
|
2023
Q4 | $10.3M | Sell |
245,000
-928,662
| -79% | -$39.1M | 0.38% | 59 |
|
|
2023
Q3 | $45.1M | Sell |
1,173,662
-911,338
| -44% | -$35M | 1.81% | 18 |
|
|
2023
Q2 | $39.6M | Buy |
2,085,000
+1,042,000
| +100% | +$19.8M | 1.38% | 30 |
|
|
2023
Q1 | $16.2M | Buy |
+1,043,000
| New | +$16.2M | 0.54% | 58 |
|